Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders. Last week the CJEU published its keenly awaited judgments concerning several well-known pharmaceutical companies which provide welcome guidance. Read the article in full on BioTalk here.
| less than a minute read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Get in touch
Get in touch
Get in touch
Get in touch
Latest Insights
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-02-23-11-15-41-283-699c36dd2077178a60ee8e64.png)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-02-19-12-04-25-086-6996fc49ed31acc93b14048e.png)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2026-02-12-10-21-37-812-698da9b1ba0ab8b6dcf40d4a.jpg)
/Passle/64ef1c9c95186b4923406017/MediaLibrary/Images/2025-08-08-16-41-13-953-689628a94a54c24e51d06f95.png)